ZA9710643B - 5-cyclo indole compounds - Google Patents

5-cyclo indole compounds

Info

Publication number
ZA9710643B
ZA9710643B ZA9710643A ZA9710643A ZA9710643B ZA 9710643 B ZA9710643 B ZA 9710643B ZA 9710643 A ZA9710643 A ZA 9710643A ZA 9710643 A ZA9710643 A ZA 9710643A ZA 9710643 B ZA9710643 B ZA 9710643B
Authority
ZA
South Africa
Prior art keywords
loweralkyl
optionally substituted
membered
independently selected
ht1d
Prior art date
Application number
ZA9710643A
Other languages
English (en)
Inventor
Abdelmalik Slassi
Louise Edwards
Qingchang Meng
Sumanas Rakhit
Original Assignee
Allelix Biopharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allelix Biopharma filed Critical Allelix Biopharma
Publication of ZA9710643B publication Critical patent/ZA9710643B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
  • Hybrid Cells (AREA)
ZA9710643A 1996-11-26 1997-11-26 5-cyclo indole compounds ZA9710643B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75580596A 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
ZA9710643B true ZA9710643B (en) 1998-09-02

Family

ID=25040731

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710643A ZA9710643B (en) 1996-11-26 1997-11-26 5-cyclo indole compounds

Country Status (12)

Country Link
EP (1) EP0944595B1 (xx)
JP (1) JP2001504501A (xx)
CN (1) CN1289479C (xx)
AT (1) ATE251136T1 (xx)
AU (1) AU738668B2 (xx)
CA (1) CA2273328C (xx)
DE (1) DE69725337T2 (xx)
ES (1) ES2208955T3 (xx)
HK (1) HK1026689A1 (xx)
TW (1) TW432059B (xx)
WO (1) WO1998023587A1 (xx)
ZA (1) ZA9710643B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100291A (en) * 1998-03-16 2000-08-08 Allelix Biopharmaceuticals Inc. Pyrrolidine-indole compounds having 5-HT6 affinity
US6251893B1 (en) * 1998-06-15 2001-06-26 Nps Allelix Corp. Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
US6329390B1 (en) * 1998-07-17 2001-12-11 Nps Allelix Corp. 5-Bicycloindole compounds
US6562809B1 (en) * 1998-09-18 2003-05-13 Nps Allelix Corp. 3-bicycloindole compounds
WO2000038677A1 (en) * 1998-12-23 2000-07-06 Allelix Biopharmaceuticals Inc. Indole and indolizidine derivatives for the treatment of migraine
DK1355904T3 (da) 2000-12-22 2007-10-15 Wyeth Corp Heterocyclindazol- og -azaindazolforbindelser som 5-hydroxytryptamin-6-ligander
EP1803720A1 (en) * 2000-12-22 2007-07-04 Wyeth a Corporation of the State of Delaware Heterocyclindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
CA2515571A1 (en) 2003-02-14 2004-09-02 Wyeth Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
US8030257B2 (en) 2005-05-13 2011-10-04 Exxonmobil Research And Engineering Company Catalytic antioxidants
CN102936240A (zh) * 2012-10-30 2013-02-20 浙江省医学科学院 一种(r)-5-取代-3-(n-苄氧羰基吡咯烷-2-基羰基)-1h-吲哚的合成方法
CN107698558B (zh) * 2017-10-24 2019-04-02 温州大学 一种氮杂环硫化物的制备方法及其净化提纯方法
TW201938517A (zh) * 2017-12-01 2019-10-01 景凱生物科技股份有限公司 苯並雜環化合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
GB9226537D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5300645A (en) * 1993-04-14 1994-04-05 Eli Lilly And Company Tetrahydro-pyrido-indole
BR9406481A (pt) * 1993-04-22 1996-01-09 Pfizer Res & Dev Derivados de indol como agonistas do tipo 5-HT1 para utilização na enxaqueca

Also Published As

Publication number Publication date
CA2273328C (en) 2009-04-28
DE69725337T2 (de) 2004-07-15
ATE251136T1 (de) 2003-10-15
JP2001504501A (ja) 2001-04-03
EP0944595A1 (en) 1999-09-29
EP0944595B1 (en) 2003-10-01
HK1026689A1 (en) 2000-12-22
AU738668B2 (en) 2001-09-20
TW432059B (en) 2001-05-01
DE69725337D1 (de) 2003-11-06
CA2273328A1 (en) 1998-06-04
WO1998023587A1 (en) 1998-06-04
ES2208955T3 (es) 2004-06-16
AU5112298A (en) 1998-06-22
CN1289479C (zh) 2006-12-13
CN1245491A (zh) 2000-02-23

Similar Documents

Publication Publication Date Title
ZA9710643B (en) 5-cyclo indole compounds
BR0013427A (pt) Compostos heteropolicìclicos e seus usos como antagonistas no receptor de glutamato metabotrópico
AU640417B2 (en) Substituted 5-((tetrazolyl)alkenyl)imidazoles
SE8503680D0 (sv) Indolderivat
NO962539D0 (no) 5-(2-imidazolinylamino)benzimidazol-derivater, deres fremstilling og deres anvendelse som -2-adreniceptor-agonister
FI873631A (fi) --alkyl-4-amino-3-kinolinmetanoler och 1-(4-aralkylamino-3-kinolinyl)alkanoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ATE12042T1 (de) Aminosaeurederivate und ihre therapeutische verwendung.
BR0114552A (pt) N1- (benzenosulfonil) indóis 2-,3-,4-, 5- substituìdos e seu uso em terapia
NO904799L (no) Substituerte n-(imidazolyl)alkylalanin-derivater.
PT1189923E (pt) Derivados aromaticos e heterociclicos de fitosterois e/ ou fitostanois para utilizacao no tratamento ou prevencao de doenca cardiovascular
AU8380282A (en) 1-(3-halo-2-pyridinyl) piperazine
KR950002761A (ko) 강박 반응 장애 치료제 제조용으로서의 n-(피리디닐)-1h-인돌-1-아민의 용도
SE9201076D0 (sv) The use of old drugs for the treatment of diabetes
CA2175352A1 (en) 3-Aryl-4-Alkyl and 4,5-Dialkyl-4H-1,2,4-Triazoles Useful as Memory Enhancers
DE69114404D1 (de) 1-(Pyridinylalkyl)-1H-indole, -indoline und Analoge.
DK423186A (da) Spiro-(benzofuran-2(3h),1`cycloheptan)-derivater, deres fremstilling og anvendelse samt mellemprodukt til fremstillingen
DK114386D0 (da) Benzo(c)-1,5-naphthyridiner, fremgangsmaade og mellemprodukter til fremstilling deraf og deres anvendelse som laegemidler
NO932002L (no) Nye tiosemikarbazonsyreestere
DE69909097D1 (de) 5-bicycloindolverbindungen
NO902556D0 (no) 4,5,5a,6-tetrahydro-3h-isoksazol(5,4,3-kl)akridinderivater og fremgangsmaate for fremstilling derav.
DE69405901T2 (de) 2, 3-Dihydro-4(1H)-quinazolinone zu Magen-Darmtherapien
TH20772A (th) อนุพันธ์(3-(4-เฟนิลเพทเพทอราซิน-1-อิล) โพรพิลอมิโน)-ไพริดีน,ไพริมิดีนและเบนซีน การใช้สารเห่านี้เป็นยาและการเตรียมสารเหล่านี้